Ozempic-maker Novo Nordisk to cut 9,000 jobs

Novo Nordisk, a manufacturer of Wegovy and Özempic, announced that the snow will cut 9,000 jobs after 9,000 work, warning that more “knockout” weight loss drugs will occur.

Dispositions make up 11% of the Danish company’s labor force, and Novo Nordisk is faced with pressures in the rapidly expanding weight loss sector, while the new general manager Mike Dustdar points to the first big step.

The demand for weight loss drugs has increased in recent years after lockings related to Covid have been forcing people to stay in their homes.

“Since it becomes more competitive and consumer -oriented, our markets are developing especially in obesity. Our company should develop.”

Novo Nordisk faced increasing competition from competitors like Eli Lilly, who made Mounjaro.

Eli Lilly recently increased Mounjaro’s price in the UK and caused some patients to warn that they could not keep the drug because the rise had stocked the drug before entering into force.

The company announced that Mounjaro’s price would increase up to 170%, which means that the highest one -month highest dose supply will rise from £ 122 to £ 330.

In Novo Nordisk, the company warned that in July, full year sales and profits will not grow as fast as expected.

By the end of next year, the company aims to reduce costs by 8 billion Denmark (£ 927 million).

In July, Novo Nordisk warned that full -year sales and profits will not grow as fast as expected.

Mr. Dustdar, “Talented and valuable colleagues are always difficult to see, although it is difficult to do, Novo Nordisk’s long -term success to be convinced that the right thing to be done,” he said.

The company said it would start to discuss with employees in accordance with local labor laws in the coming months.

It will share more details when it reports its financial results on November 5th.

There are two drugs on the market – Semaglidid, marketed under the brand of Wegovy and sold as Mounjaro.

Semagluid injections are used to treat diabetes, but in recent years, people who want to lose weight have become wildly popular among people.

It is given as weekly injections by means of pre -filled pens that can be applied to the upper arm, thigh or stomach.

Both drugs work as an appetite suppression by imitating a hormone that makes people feel fuller. Mounjaro also affects metabolism and helps to regulate energy balance.

Patients usually start at a low -level dose, which is gradually increased until it reaches a care dose.